A Buzz to the Neck: Vibration Therapy Shows Promise for Positional Sleep Apnea
A new randomized controlled trial demonstrates the efficacy of a novel, non-invasive device for managing positional obstructive sleep apnea (POSA). The study evaluated a neck-worn device that delivers vibrotactile feedback to discourage supine sleeping, a key trigger for airway collapse in POSA. Over three months, the active therapy significantly reduced the apnea-hypopnea index (AHI) by 34% compared to a sham device, equating to a reduction of 4.41 events per hour. While the intervention improved overall sleep quality as measured by the Pittsburgh Sleep Quality Index, it did not lead to a statistically significant reduction in daytime sleepiness on the Epworth Sleepiness Scale. Importantly, bed partners reported notable improvements in patient snoring and sleep quality, and over half of the participants chose to continue using the device after the trial.
Study Significance: This research provides robust, level-one evidence for a wearable technology that directly addresses the pathophysiology of positional sleep apnea. For pulmonologists and sleep specialists, it introduces a credible, patient-friendly alternative or adjunct to continuous positive airway pressure (CPAP) for a specific OSA phenotype, potentially improving adherence and expanding the therapeutic toolkit. The findings underscore the value of targeted positional therapy and highlight objective metrics like AHI and partner-reported outcomes as crucial for evaluating new sleep apnea interventions in clinical practice.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
